17 Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Buy |
1,020
+20
| +2% | +$8.9K | 0.26% | 101 |
|
|
2025
Q1 | $485K | Buy |
1,000
+5
| +0.5% | +$2.42K | 0.31% | 97 |
|
|
2024
Q4 | $401K | Buy |
995
+3
| +0.3% | +$1.21K | 0.25% | 107 |
|
|
2024
Q3 | $461K | Buy |
992
+2
| +0.2% | +$930 | 0.3% | 94 |
|
|
2024
Q2 | $464K | Buy |
990
+50
| +5% | +$23.4K | 0.33% | 84 |
|
|
2024
Q1 | $393K | Sell |
940
-985
| -51% | -$412K | 0.29% | 87 |
|
|
2023
Q4 | $783K | Buy |
+1,925
| New | +$783K | 0.72% | 53 |
|
|
2022
Q3 | $431K | Hold |
1,490
| – | – | 0.59% | 62 |
|
|
2022
Q2 | $420K | Hold |
1,490
| – | – | 0.53% | 63 |
|
|
2022
Q1 | $389K | Buy |
1,490
+350
| +31% | +$91.4K | 0.41% | 72 |
|
|
2021
Q4 | $250K | Buy |
+1,140
| New | +$250K | 0.23% | 84 |
|
|
2021
Q3 | – | Sell |
-1,651
| Closed | -$333K | – | 102 |
|
|
2021
Q2 | $333K | Buy |
+1,651
| New | +$333K | 0.31% | 85 |
|